Author: Moritani Y. Sato K. Shigenaga T. Hisamichi N. Ichihara M. Akamatsu S. Suzuki K.-i. Nii T. Kaku S. Kawasaki T. Matsumoto Y. Inagaki O. Tomioka K. Yanagisawa I.
Publisher: Elsevier
ISSN: 0014-2999
Source: European Journal of Pharmacology, Vol.439, Iss.1, 2002-03, pp. : 43-52
Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.
Abstract
Related content
Platelet glycoprotein IIb/IIIa receptor antagonists
By Casserly I.P. Moliterno D.J.
Expert Opinion on Pharmacotherapy, Vol. 1, Iss. 3, 2000-03 ,pp. :
Potential Role of Platelet Glycoprotein IIb/IIIa Antagonists in Cerebrovascular Disorders
By Mousa S.A.
CNS Drugs, Vol. 13, Iss. 3, 2000-03 ,pp. :
Platelet Glycoprotein IIb/IIIa Receptor Antagonists And Their Use In Elderly Patients
By Mak K-H.
Drugs & Aging, Vol. 16, Iss. 3, 2000-03 ,pp. :